HB6963: Pediatric Cancer Drug Supply Act of 2024
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To direct the Secretary of Health and Human Services to enter into agreements with drug manufacturers to establish reserve supplies of covered pediatric cancer drugs, and for other purposes.
Plain-language summary
The Pediatric Cancer Drug Supply Act of 2024 directs the Secretary of Health and Human Services to work with drug manufacturers to keep emergency backup supplies of cancer drugs used to treat children. These reserve supplies would ensure pediatric cancer patients have access to needed medications if normal supply chains are disrupted. The bill addresses potential drug shortages that could affect children undergoing cancer treatment. The bill is currently in the introduction stage and has not yet been assigned to a for consideration.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB6963: Pediatric Cancer Drug Supply Act of 2024
Upcoming hearings & events
Sponsors
Anna Eshoo
Primary SponsorCo-sponsors (15)
Diana DeGette
Kim Schrier
Lori Trahan
Darren Soto
Kathy Castor